Page 13 - The Netter Collection of Medical Illustrations - Integumentary System_ Volume 4 ( PDFDrive )
P. 13

CONTENTS








         SECTION 1                                 3-7  Cutaneous Metastases,  58           4-35  Granuloma Annulare,  106
        ANATOMY, PHYSIOLOGY, AND                   3-8  Dermatofibrosarcoma Protuberans,  59  4-36  Graves Disease and Pretibial
                                                                                                 Myxedema,  107
        EMBRYOLOGY                                 3-9  Mammary and Extramammary Paget’s    4-37  Hidradenitis Suppurativa (Acne
                                                       Disease,  60
         1-1  Embryology of the Skin,  2          3-10  Kaposi’s Sarcoma,  61                    Inversa),  108
         1-2  Normal Skin Anatomy,  3             3-11  Keratoacanthoma,  62                4-38  Irritant Contact Dermatitis,  109
         1-3  Normal Skin Histology,  4           3-12  Melanoma: Mucocutaneous             4-39  Keratosis Pilaris,  110
         1-4  Skin Physiology—The Process of           Malignant Melanoma,  63              4-40  Langerhans Cell Histiocytosis: Presentation
             Keratinization,  5                   3-13  Melanoma: Metastatic Melanoma,  64       in Childhood,  111
         1-5  Normal Skin Flora,  6               3-14  Merkel Cell Carcinoma,  65          4-41  Langerhans Cell Histiocytosis: Eosinophilic
         1-6  Vitamin D Metabolism,  7            3-15  Mycosis Fungoides: Clinical Subtypes of   Granuloma,  112
         1-7  Photobiology,  8                         Cutaneous T-Cell Lymphoma,  66       4-42  Leukocytoclastic Vasculitis,  113
         1-8  Wound Healing,  9                   3-16  Mycosis Fungoides: Histological Analysis of   4-43  Lichen Planus,  114
         1-9  Morphology: Lichenification, Plaques, and   Cutaenous T-Cell Lymphoma,  67    4-44  Lichen Simplex Chronicus,  115
             Fissures,  10                        3-17  Sebaceous Carcinoma,  68            4-45  Lower Extremity Vascular
        1-10  Morphology: Macules, Patches, and   3-18  Squamous Cell Carcinoma: Genital         Insufficiency,  116
             Vesiculo-Pustules,  11                    Squamous Cell Carcinoma,  69         4-46  Mast Cell Diesase,  117
                                                  3-19  Squamous Cell Carcinoma: Clinical and   4-47  Mast Cell Disease: Degranulation
         SECTION 2                                     Histological Evaluation,  70              Blockers,  118
                                                                                            4-48  Morphea,  119
        BENIGN GROWTHS                                                                      4-49  Myxedema,  120
         2-1  Acrochordon,  14                     SECTION 4                                4-50  Necrobiosis Lipoidica,  121
         2-2  Becker’s Nevus (Smooth Muscle       RASHES                                    4-51  Necrobiotic Xanthogranuloma,  122
             Hamartoma),  15                       4-1  Acanthosis Nigricans,  72           4-52  Neutrophilic Eccrine Hidradenitis,  123
         2-3  Dermatofibroma (Sclerosing           4-2  Acne Vulgaris,  73                  4-53  Ochronosis: Metabolic Pathway and
             Hemangioma),  16                      4-3  Acne Variants,  74                       Cutaneous Findings,  124
         2-4  Eccrine Poroma,  17                  4-4  Acne Keloidalis Nuchae,  75         4-54  Ochronosis: Systemic Findings,  125
         2-5  Eccrine Spiradenoma,  18             4-5  Acute Febrile Neutrophilic          4-55  Oral Manifestations in Blood
         2-6  Eccrine Syringoma,  19                   Dermatosis (Sweet’s Syndrome),  76        Dyscrasias,  126
         2-7  Ephelides and Lentigines,  20        4-6  Allergic Contact Dermatitis:        4-56  Phytophotodermatitis,  127
         2-8  Ephelides and Lentigines (Continued),  21  Morphology,  77                    4-57  Pigmented Purpura,  128
         2-9  Epidermal Inclusion Cyst,  22        4-7  Allergic Contact Dermatitis: Patch Testing   4-58  Pityriasis Rosea,  129
        2-10  Epidermal Nevus,  23                     and Type IV Hypersensitivity,  78    4-59  Pityriasis Rubra Pilaris,  130
        2-11  Fibrofolliculoma,  24                4-8  Atopic Dermatitis: Infants and      4-60  Polyarteritis Nodosa,  131
        2-12  Fibrous Papule,  25                      Children,  79                        4-61  Pruritic Urticarial Papules and Plaques Of
        2-13  Ganglion Cyst,  26                   4-9  Atopic Dermatitis: Adolescents and       Pregnancy,  132
        2-14  Glomus Tumor and Glomangioma,  27        Adults,  80                          4-62  Pseudoxanthoma Elasticum,  133
        2-15  Hidradenoma Papilliferum,  28       4-10  Autoinflammatory Syndromes:         4-63  Psoriasis: Histopathological Features and
        2-16  Hidrocystoma,  29                        Pathophysiology,  81                      Typical Distribution,  134
        2-17  Keloid and Hypertrophic Scar,  30   4-11  Autoinflammatory Syndromes: Clinical   4-64  Psoriasis: Inverse Psoriasis and Psoriasis in
        2-18  Leiomyoma,  31                           Manifestations,  82                       the Genital Area,  135
        2-19  Lichenoid Keratosis,  32            4-12  Bug Bites: Brown Recluse Spiders and   4-65  Psoriasis: Psoriatic Arthritis,  136
        2-20  Lipoma,  33                              Scabies Mites,  83                   4-66  Radiation Dermatitis,  137
        2-21  Median Raphe Cyst,  34              4-13  Bug Bites: Arthropods and Diseases They   4-67  Reactive Arthritis (Reiter’s Syndrome),  138
        2-22  Melanocytic Nevi: Blue Nevi,  35         Carry,  84                           4-68  Rosacea,  139
        2-23  Melanocytic Nevi: Common Acquired   4-14  Calciphylaxis,  85                  4-69  Sacroid: Cutaneous Manifestations,  140
             Nevi and Giant Congenital Melanocytic   4-15  Cutaneous Lupus: Band Test,  86  4-70  Sarcoid: Systemic Manifestations,  141
             Nevi,  36                            4-16  Cutaneous Lupus: Systemic Manifestations   4-71  Scleroderma (Progressive Systemic
        2-24  Melanocytic Nevi: Congenital Nevi,  37   of Systemic Lupus Erythematosus,  87      Sclerosis),  142
        2-25  Milia,  38                          4-17  Cutaneous Lupus: Manifestations,  88  4-72  Seborrheic Dermatitis,  143
        2-26  Neurofibroma,  39                   4-18  Cutis Laxa,  89                     4-73  Skin Manifestations of Inflammatory
        2-27  Nevus Lipomatosus Superficialis,  40  4-19  Dermatomyositis: Manifestations,  90   Bowel Disease: Mucocutaneous
        2-28  Nevus of Ota and Nevus of Ito,  41  4-20  Dermatomyositis: Cutaneous and           Manifestations,  144
        2-29  Nevus Sebaceus,  42                      Laboratory Findings,  91             4-74  Skin Manifestations of Inflammatory
        2-30  Osteoma Cutis,  43                  4-21  Disseminated Intravascular Coagulation,  92  Bowel Disease: Cutaneous
        2-31  Palisaded Encapsulated Neuroma,  44  4-22  Elastosis Perforans Serpiginosa,  93    Manifestations,  145
        2-32  Pilar Cyst (Trichilemmal Cyst),  45  4-23  Eruptive Xanthomas: Congenital     4-75  Stasis Dermatitis,  146
        2-33  Porokeratosis,  46                       Hyperlipoproteinemia,  94            4-76  Urticaria,  147
        2-34  Pyogenic Granuloma,  47             4-24  Eruptive Xanthomas: Acquired        4-77  Vitiligo,  148
        2-35  Reticulohistiocytoma,  48                Hyperlipoproteinemia,  95
        2-36  Seborrheic Keratosis,  49           4-25  Erythema Ab Igne,  96
        2-37  Spitz Nevus,  50                    4-26  Erythema Annulare Centrifugum,  97   SECTION 5
                                                  4-27  Erythema Multiforme, Stevens-Johnson   AUTOIMMUNE BLISTERING DISEASES
         SECTION 3                                     Syndrome, and Toxic Epidermal         5-1  Basement Membrane Zone and
                                                       Necrolysis,  98                           Hemidesmosome,  150
        MALIGNANT GROWTHS                         4-28  Erythema Multiforme, Stevens-Johnson   5-2  Desmosome,  151
         3-1  Adnexal Carcinoma,  52                   Syndrome, and Toxic Epidermal Necrolysis   5-3  Bullous Pemphigoid,  152
         3-2  Angiosarcoma,  53                        (Continued),  99                      5-4  Mucous Membrane Pemphigoid,  153
         3-3  Basal Cell Carcinoma: Basic Facial   4-29  Erythema Nodosum,  100              5-5  Dermatitis Herpetiformis,  154
             Anatomy,  54                         4-30  Fabry Disease,  101                  5-6  Epidermolysis Bullosa Acquisita,  155
         3-4  Basal Cell Carcinoma: Clinical and   4-31  Fixed Drug Eruption,  102           5-7  Linear IgA Bullous Dermatosis,  156
             Histological Evaluation,  55         4-32  Gout: Gouty Arthritis,  103          5-8  Paraneoplastic Pemphigus,  157
         3-5  Bowen’s Disease,  56                4-33  Gout: Tophaceous Gout,  104          5-9  Pemphigus Foliaceus,  158
         3-6  Bowenoid Papulosis,  57             4-34  Graft-versus-Host Disease,  105     5-10  Pemphigus Vulgaris,  159


        THE NETTER COLLECTION OF MEDICAL ILLUSTRATIONS                                                                            xi
   8   9   10   11   12   13   14   15   16   17   18